Clinical trial
Oral Prednisolone for Acute Rhinovirus Induced Wheezing in Children Less Than 2 Years of Age: a Point-of-care Testing Guided Randomized, Double-blind, Placebo-controlled Trial
NCT05444699 is registered in ClinicalTrials.gov with University of Oulu as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Oral Prednisolone for Acute Rhinovirus Induced Wheezing in Children Less Than 2 Years of Age: a Point-of-care Testing Guided Randomized, Double-blind, Placebo-controlled Trial
- Lead sponsor
- University of Oulu
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- October 11, 2022
- Completion date
- September 30, 2027
- Enrollment
- 210 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
bronchiolitis acute viral